# MycoMedica

**Canonical:** https://apis.io/providers/mycomedica/  
**Website:** https://www.mycomedica.com  
**APIs profiled:** 0

MycoMedica Life Sciences, PBC is a clinical-stage biopharmaceutical company founded by mycologist Paul Stamets and backed by Obvious Ventures, True Ventures, and Kittyhawk Ventures. The company develops fungi-derived therapeutic drugs, including its lead psilocybin candidate MLS101 and the "Stamets Stack" (a novel blend of niacin, psilocybin, and lion's mane), for the prevention and treatment of psychiatric and neurological disorders. It raised $60 million in Series A funding in 2022 and is advancing pre-clinical and clinical research toward FDA approval. MycoMedica is a life-sciences drug-development company and publishes no public developer API, documentation, or developer portal.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biopharmaceutical, Life Sciences, Drug Development, Psychedelics, Mental Health, Neuroscience, Mycology

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/mycomedica/). Scores are computed from the provider's own public artifacts under a published rubric.